William A Werbel Selected Research

Musculoskeletal Diseases (Musculoskeletal Disease)

4/2022	Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease.
1/2022	Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
10/2021	Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
10/2021	High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.
1/2021	Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
1/2021	Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William A Werbel Research Topics

Disease

14	COVID-19 01/2022 - 01/2020
6	Musculoskeletal Diseases (Musculoskeletal Disease) 04/2022 - 01/2021
4	Infections 10/2022 - 10/2019
2	Coinfection 01/2022 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2022
2	Breakthrough Infections 01/2022 - 10/2021
1	Necrosis 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Multiple Myeloma 12/2021
1	Rheumatic Diseases (Rheumatism) 11/2021
1	Pain (Aches) 10/2021
1	Severe Acute Respiratory Syndrome 07/2021
1	Hepatitis 01/2021

Drug/Important Bio-Agent (IBA)

8	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
4	mRNA VaccinesIBA 04/2022 - 01/2021
4	VaccinesIBA 01/2022 - 07/2021
3	COVID-19 VaccinesIBA 01/2022 - 10/2021
1	remdesivirIBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Basiliximab FDA Link 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	dicarboxydine (DCD)IBA 11/2020
1	SuspensionsIBA 01/2020
1	Voriconazole (Vfend)FDA LinkGeneric 10/2019
1	liposomal amphotericin B FDA Link 10/2019
1	Antiviral Agents (Antivirals)IBA 01/2019

Therapy/Procedure

4	Kidney Transplantation 01/2021 - 01/2020
4	Transplantation 12/2020 - 01/2020
2	Organ Transplantation 10/2022 - 01/2020
2	Therapeutics 01/2022 - 01/2022
2	Liver Transplantation 01/2021 - 01/2021
1	Immunomodulation 01/2022